Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite.

MLA

Li, Guang-xun, et al. “Superior in Vivo Inhibitory Efficacy of Methylseleninic Acid against Human Prostate Cancer over Selenomethionine or Selenite.” Carcinogenesis, vol. 29, no. 5, May 2008, pp. 1005–12. EBSCOhost, https://doi.org/10.1093/carcin/bgn007.

APA

Li, G., Lee, H.-J., Wang, Z., Hu, H., Liao, J. D., Watts, J. C., Combs, G. F., Jr, & Lü, J. (2008). Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite. Carcinogenesis, 29(5), 1005–1012. https://doi.org/10.1093/carcin/bgn007

Chicago

Li, Guang-xun, Hyo-Jeong Lee, Zhe Wang, Hongbo Hu, Joshua D Liao, Jennifer C Watts, Gerald F Combs Jr, and Junxuan Lü. 2008. “Superior in Vivo Inhibitory Efficacy of Methylseleninic Acid against Human Prostate Cancer over Selenomethionine or Selenite.” Carcinogenesis 29 (5): 1005–12. doi:10.1093/carcin/bgn007.